Načítá se...
Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?
Pancreatic cancer is projected to become the second leading cause of cancer-related death in the US by 2020. Because of this, significant interest and research funding has been devoted to development of a screening test to identify individuals during a prolonged asymptomatic period, however, to date...
Uloženo v:
| Vydáno v: | Cancer Prev Res (Phila) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089111/ https://ncbi.nlm.nih.gov/pubmed/33148677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-20-0426 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|